ID20581A - Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen - Google Patents

Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen

Info

Publication number
ID20581A
ID20581A IDW980025D ID980025D ID20581A ID 20581 A ID20581 A ID 20581A ID W980025 D IDW980025 D ID W980025D ID 980025 D ID980025 D ID 980025D ID 20581 A ID20581 A ID 20581A
Authority
ID
Indonesia
Prior art keywords
antigens
rotavirus
vaccines
methods
diagnostic agents
Prior art date
Application number
IDW980025D
Other languages
English (en)
Inventor
Osamu Nakagomi
Toyoko Nakagomi
Shigeki Murakami
Tadashi Imagawa
Original Assignee
Res Fnd For Micbial Diseases O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Fnd For Micbial Diseases O filed Critical Res Fnd For Micbial Diseases O
Publication of ID20581A publication Critical patent/ID20581A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW980025D 1996-10-18 1997-10-20 Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen ID20581A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31254796 1996-10-18

Publications (1)

Publication Number Publication Date
ID20581A true ID20581A (id) 1999-01-21

Family

ID=18030536

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW980025D ID20581A (id) 1996-10-18 1997-10-20 Antigen rotavirus, vaksin dan agen diagnostik untuk infeksi rotavirus, serta metode untuk menghasilkan antigen

Country Status (7)

Country Link
US (1) US6110724A (id)
EP (1) EP0878541A4 (id)
KR (1) KR19990072201A (id)
CN (1) CN1209837A (id)
ID (1) ID20581A (id)
PE (1) PE72699A1 (id)
WO (1) WO1998017785A1 (id)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030165543A1 (en) * 2000-01-27 2003-09-04 Langridge William H.R. Transgenic plant-based vaccines
US20050241024A1 (en) * 1997-10-07 2005-10-27 Langridge William H Transgenic plant-based vaccines
US7422747B2 (en) * 1997-10-07 2008-09-09 Loma Linda University Transgenic plant-based vaccines
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
JP4540795B2 (ja) * 2000-03-10 2010-09-08 一般財団法人阪大微生物病研究会 生ワクチンの細胞性免疫活性を不活化ワクチンにも起こさせる方法、及びこれより得られる混合ワクチン
DE10144903A1 (de) * 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
CA2463927A1 (en) * 2001-10-16 2003-04-24 Raven Biotechnologies, Inc. Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
WO2004043239A2 (en) 2002-11-13 2004-05-27 Raven Biotechnologies, Inc. Antigen pipa and antibodies that bind thereto
CA2698392C (en) 2007-09-04 2019-12-03 Baoming Jiang Thermal inactivation of rotavirus
WO2009082002A1 (ja) 2007-12-26 2009-07-02 The Kitasato Institute 安定に長期間保存できる日本脳炎ワクチンの製法方法及び該ワクチンの用途
GB201011502D0 (en) * 2010-07-08 2010-08-25 Glaxosmithkline Biolog Sa Novel process
US20140065599A1 (en) * 2012-08-22 2014-03-06 The Regents Of The University Of California Novel polymavirus associated with diarrhea in children
MA44557B1 (fr) * 2016-06-16 2021-11-30 Bharat Biotech Int Ltd Vaccin contre le rotavirus sans tampon, stable en milieu acide, et d'un faible volume de dose à administrer
RU2743300C1 (ru) * 2020-06-19 2021-02-16 Федеральное Бюджетное Учреждение Науки «Ростовский Научно-Исследовательский Институт Микробиологии И Паразитологии» Способ инактивации культурального ротавируса человека
CN112941036B (zh) * 2021-02-08 2023-06-09 吉林惠康生物药业有限公司 一种提高狂犬病毒在人二倍体细胞中复制水平的方法
CN113186170B (zh) * 2021-05-26 2022-08-23 西南民族大学 一株猪轮状病毒株及其制备的灭活疫苗和用途
CN116355079B (zh) * 2022-08-19 2023-12-26 上海迈科康生物科技有限公司 检测重组人轮状病毒vp8抗原（vp8 p[8]）的单克隆抗体及其应用
CN120173890B (zh) * 2025-01-17 2026-07-03 江苏立维斯德生物技术有限公司 人轮状病毒毒种rv009毒株及其分离、培养及鉴定方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE445466B (sv) * 1977-12-01 1986-06-23 Wellcome Found Sett att foroka rotavirus in vitro
EP0152295B1 (en) * 1984-02-09 1991-03-20 Royal Children's Hospital Research Foundation Live attenuated human rotavirus vaccine and preparation thereof
DE3582180D1 (de) * 1984-02-09 1991-04-25 Royal Children S Hospital Rese Lebender attenuierter menschlicher rotavirus-impfstoff und herstellung desselben.
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
AU618973B2 (en) * 1987-11-30 1992-01-16 Children's Hospital Foundation, The Novel rotavirus reassortant vaccine
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
WO1992008786A1 (en) * 1990-11-16 1992-05-29 James N. Gamble Institute Of Medical Research Human rotaviruses, vaccines and methods
US5610049A (en) * 1991-05-01 1997-03-11 The Wistar Institute Of Anatomy And Biology Human rotavirus HCR3A and method of growing said rotavirus
WO1996001651A1 (en) * 1994-07-11 1996-01-25 The Government Of The United States Of America, Represented By The Department Of Health And Human Services Attenuated human rotavirus vaccine
ATE542891T1 (de) * 1994-11-10 2012-02-15 Baxter Healthcare Sa Verfahren zur herstellung von biologischen produkten in protein-freier kultur

Also Published As

Publication number Publication date
WO1998017785A1 (en) 1998-04-30
EP0878541A4 (en) 2001-10-17
PE72699A1 (es) 1999-08-06
CN1209837A (zh) 1999-03-03
US6110724A (en) 2000-08-29
KR19990072201A (ko) 1999-09-27
EP0878541A1 (en) 1998-11-18

Similar Documents

Publication Publication Date Title
NO20010576D0 (no) Immunologiske herpes simplex-virusantigener og fremgangsmåte for anvendelse derav
CY2019029I1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
NL300415I1 (nl) Vaccin tegen antigenen van bacteriën
ATE347600T1 (de) Gruppe b-streptococcus antigene
ES2093778T3 (es) Nuevos anticuerpos y metodos para su uso.
DK0642355T3 (da) Kombinerede vacciner, der omfatter hepatitis B-overfladeantigen og andre antigener
WO2001060402A3 (en) Proteosome influenza vaccine
DK0724432T3 (da) Fremgangsmåder og præparater til mikroindkapsling af antigener til brug som vacciner
EP1028749A4 (en) ENTEROCOCCUS ANTIGENS AND VACCINE
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
DE69530078D1 (de) Antigen/antikörper spezifitätsaustauscher
DE60129278D1 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
EP1412538A4 (en) PROCESS FOR SIMULTANEOUS DETECTION OF HCV ANTIGENES AND HCV ANTIBODIES
DE60045870D1 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
ATE530572T1 (de) Antigen-cocktails, p35 und verwendungen dafür
WO2002054073A3 (en) Latent human tuberculosis model, diagnostic antigens, and methods of use
IS6381A (is) Nýjung við notkun mótefna í bóluefni
EP1700122A4 (en) IMMUNOASSAYS, HAPTENE, IMMUNOGENES AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS
EP0551308A4 (en) Novel peptide antigens and immunoassays, test kits and vaccines using the same
ID17131A (id) Pembiakkan lawsonia intracellularis, zat diagnostik dan vaksin anti-lawsonia intracellularis
ID28905A (id) Antibodi-antibodi dengan afinitas tinggi
FI953371L (fi) TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi
CA2333598A1 (en) Toxoplasma gondii antigens, p35, and uses thereof
AU2002215215A1 (en) Antibody against norwalk virus and method of detecting virus by using the antibody
ITRM910385A1 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni